Presentation on ASX Gems Conference on 21st June, page-28

First 28 Last

Share
Profile

Follow
stockman49

612 Posts.

99

19/06/24

22:12

Post #: 74399715
Share

Originally posted by Keith58: ↑

To me, the temporal context is important. The product certainly seems to be "in front of" the FDA now as Silviu goes on to state words, to the effect, "if approval is granted.....". Such approval cannot happen unless the resubmission has already occurred.

If such is not the case then Mr Itescu has been very clumsy (and loose) with his words. I suspect that, given past issues, he would not make such a rookie error. Irrespectively, we know that soon the resubmission will occur if it has not already done so. We'll see. I only have a modest holding so I won't have to sell my first born if my interpretation is incorrect. GLTAH cheers Keith

Expand

You should sell it any way and buy some more.
Not investment advice.

Originally posted by Keith58: ↑

To me, the temporal context is important. The product certainly seems to be "in front of" the FDA now as Silviu goes on to state words, to the effect, "if approval is granted.....". Such approval cannot happen unless the resubmission has already occurred.

If such is not the case then Mr Itescu has been very clumsy (and loose) with his words. I suspect that, given past issues, he would not make such a rookie error. Irrespectively, we know that soon the resubmission will occur if it has not already done so. We'll see. I only have a modest holding so I won't have to sell my first born if my interpretation is incorrect. GLTAH cheers Keith

Expand

MSB Price at posting: $1.09 Sentiment: Buy Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

STX

Strike Energy secures $153 million for Perth Basin gas projects

There are more pages in this discussion • 168 more messages in this thread...

First 28 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 99.0¢		Change -0.035(3.41%)		Mkt cap ! $1.130B

Open	High	Low	Value	Volume
$1.03	$1.04	96.5¢	$8.837M	8.885M

Buyers (Bids)

No.	Vol.	Price($)
1	59782	99.0¢

Sellers (Offers)

Price($)	Vol.	No.
99.5¢	26617	2

View Market Depth

No.	Vol.	Price($)
1	59782	0.990
1	10000	0.980
1	20000	0.975
19	191088	0.970
5	91150	0.965

Price($)	Vol.	No.
0.995	26617	2
1.000	127185	8
1.005	61027	3
1.010	5000	2
1.015	7142	3

Last trade - 16.10pm 24/06/2024 (20 minute delay)

MSB (ASX) Chart

Presentation on ASX Gems Conference on 21st June, page-28

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Cultural heritage agreement puts Walford Creek exploration back on the map

Strike Energy secures $153 million for Perth Basin gas projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Presentation on ASX Gems Conference on 21st June, page-28

Top Stories

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Cultural heritage agreement puts Walford Creek exploration back on the map

Strike Energy secures $153 million for Perth Basin gas projects

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News